Innospec — Third Quarter 2026 Earnings Summary

Financial Performance:

• Total revenues for the quarter ended September 30, 2026, were $473.6 million, a 7% increase from $441.9 million in the same period in 2025.
• Net income attributable to Innospec was $31.8 million ($1.29 per diluted share), compared to $12.9 million ($0.52 per diluted share) in the prior year period.
• Adjusted non-GAAP EPS was $1.29 per diluted share, up from $1.12 per diluted share in the third quarter of 2025.
• Adjusted EBITDA was $51.4 million, an increase from $44.2 million in the prior year period.
• Cash provided by operating activities was $17.4 million, compared to $39.1 million in the prior year quarter.
• Capital expenditures for the quarter were $15.6 million.
• Net cash position improved to $251.9 million as of September 30, 2026, with no debt outstanding.
• Corporate costs were $18.6 million, compared to $18.2 million in the prior year period.
• The adjusted effective tax rate was 24.7%, compared to 22.7% in the prior year period.

Guidance and Future Outlook:

• Innospec expects to commission plant efficiency upgrades in North Carolina by year-end, which are projected to increase capacity, productivity, and yields.
• Management anticipates further growth and margin improvement in the coming quarters as utilization of the new North Carolina capacity improves and progress on new products continues.
• For the fourth quarter, the company expects improvement in operating income driven by better activity levels in the legacy Middle East business and reduced raw material costs, following sequential results that were lower than expected due to activity delays and elevated costs.
• The company plans to focus on driving increased operating cash flow in the coming quarters through improved working capital efficiency.

Business Segments and Product Lines:

• Performance Chemicals: Revenue was $180.5 million, up 6% from $170.8 million in the prior year. Gross margins increased 3.7 percentage points to 18.8%. Operating income rose 84% to $16.9 million from $9.2 million. Volume decreased 5%, while price and product mix increased 12%, offsetting a 1% negative currency impact.
• Fuel Specialties: Revenue was $180.7 million, up 5% from $172.0 million in the prior year. Gross margins were 35.1%, a decrease of 0.5 percentage points. Operating income increased 1% to $35.6 million from $35.3 million. Volume increased 3% and price/product mix increased 2%.
• Oilfield Services: Revenue was $112.4 million, up 13% from $99.1 million in the prior year. Gross margins were 28.2%, a decrease of 1.8 percentage points due to a weaker sales mix. Operating income increased 40% to $6.7 million from $4.8 million, driven by the recent DRA plant expansion.

Market and Competitive Landscape:

• The company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, serving markets including Personal Care, Home Care, Agrochemical, Mining, Industrial, and Oil & Gas exploration and production.
• Performance Chemicals growth was driven by positive price and product mix despite volume reductions.
• Oilfield Services growth was driven by the DRA plant expansion, though legacy Middle East business faced activity delays.

Risks and Challenges:

• Oilfield Services faced sequential operating income pressure due to continued activity delays in the legacy Middle East business and elevated raw material costs.
• Performance Chemicals experienced volume reductions of 5% and a negative currency impact of 1%.
• Oilfield Services gross margins declined due to a weaker sales mix.

Management Commentary and Tone:

• Patrick S. Williams, President and CEO, described the quarter as "another good quarter" with all businesses contributing to solid revenue and strong operating income growth.
• Management highlighted significant opportunities for continued growth and margin improvement, particularly in Performance Chemicals and Oilfield Services.
• The tone was confident regarding the company's balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks.

Other Key Points:

• The Board approved a semi-annual dividend of 94 cents per common share for the second half of 2026, payable on November 25, 2026, to shareholders of record as of November 17, 2026.
• This dividend declaration brings the annual dividend to $1.86 per share, representing a 9% increase over 2025.
• The company reported no debt on its balance sheet as of September 30, 2026.
• Nine-month net sales for 2026 were $1,418.2 million, compared to $1,322.4 million in the same period of 2025.
• Nine-month adjusted EBITDA was $145.2 million, compared to $147.3 million in the prior year period.